Overall, our bioinformatic analyses highlighted the concomitant dysregulation of PAM, ER, and cell cycle-related pathways in both luminal A and luminal B breast tumors and identified several other functionally related pathways (e.g., glycolysis) whose activity could contribute to BC tumor progression. The gene discussed is ESR1; the disease is breast neoplasm.